{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:19:20Z","timestamp":1790752760565,"version":"4.1.0"},"reference-count":223,"publisher":"Elsevier","isbn-type":[{"value":"9780128112328","type":"print"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/bs.apha.2017.05.002","type":"book-chapter","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T14:01:14Z","timestamp":1499090474000},"page":"329-366","source":"Crossref","is-referenced-by-count":37,"title":["Cannabinoids in the Cardiovascular System"],"prefix":"10.1016","author":[{"given":"Wing S.V.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie E.M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apha.2017.05.002_bb0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12974-014-0191-6","article-title":"Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury","volume":"11","author":"Amenta","year":"2014","journal-title":"Journal of Neuroinflammation"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/mol.62.3.705","article-title":"Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists","volume":"62","author":"Andersson","year":"2002","journal-title":"Molecular Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00210-014-0961-9","article-title":"Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries","volume":"387","author":"Baranowska-Kuczko","year":"2014","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"B\u00e1tkai","year":"2001","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0025","doi-asserted-by":"crossref","first-page":"H595","DOI":"10.1152\/ajpheart.00184.2004","article-title":"Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors","volume":"287","author":"B\u00e1tkai","year":"2004","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"14","key":"10.1016\/bs.apha.2017.05.002_bb0030","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension","volume":"110","author":"B\u00e1tkai","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0035","doi-asserted-by":"crossref","first-page":"H909","DOI":"10.1152\/ajpheart.00373.2007","article-title":"Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase","volume":"293","author":"B\u00e1tkai","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"46","key":"10.1016\/bs.apha.2017.05.002_bb0040","doi-asserted-by":"crossref","first-page":"46188","DOI":"10.1074\/jbc.M307258200","article-title":"G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current","volume":"278","author":"Begg","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apha.2017.05.002_bb0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/cpt1979254440","article-title":"Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms","volume":"25","author":"Benowitz","year":"1979","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: Inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0060","doi-asserted-by":"crossref","first-page":"H785","DOI":"10.1152\/ajpheart.00571.2015","article-title":"Endocannabinoids in cerebrovascular regulation","volume":"310","author":"Beny\u00f3","year":"2016","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2017.05.002_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(97)01007-8","article-title":"Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells","volume":"330","author":"Berdyshev","year":"1997","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/fampra\/cms013","article-title":"Rimonabant improves obesity but not the overall cardiovascular risk and quality of life; results from CARDIO-REDUSE (CArdiometabolic risk reDuctIOn by Rimonabant: The effectiveness in daily practice and its USE)","volume":"29","author":"Boesten","year":"2012","journal-title":"Family Practice"},{"issue":"24","key":"10.1016\/bs.apha.2017.05.002_bb0075","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1111\/bph.12866","article-title":"Endothelial atypical cannabinoid receptor: Do we have enough evidence?","volume":"171","author":"Bondarenko","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00005344-200304000-00020","article-title":"Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle","volume":"41","author":"Bonz","year":"2003","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pcad.2016.04.003","article-title":"Coronary atherosclerosis: Pathophysiologic basis for diagnosis and management","volume":"58","author":"Boudoulas","year":"2016","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/micc.12276","article-title":"Experimental cannabinoid 2 receptor in CNS injury-induced immunodeficiency syndrome","volume":"23","author":"Burkovskiy","year":"2016","journal-title":"Microcirculation"},{"key":"10.1016\/bs.apha.2017.05.002_bb0095","doi-asserted-by":"crossref","first-page":"245410","DOI":"10.1155\/2008\/245410","article-title":"PPAR agonists and cardiovascular disease in diabetes","volume":"2008","author":"Calkin","year":"2008","journal-title":"PPAR Research"},{"key":"10.1016\/bs.apha.2017.05.002_bb0100","doi-asserted-by":"crossref","first-page":"824093","DOI":"10.1155\/2012\/824093","article-title":"Update on the role of cannabinoid receptors after ischemic stroke","volume":"2012","author":"Capettini","year":"2012","journal-title":"Mediators of Inflammation"},{"issue":"35","key":"10.1016\/bs.apha.2017.05.002_bb0105","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.2174\/0929867321666140915141332","article-title":"Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases","volume":"21","author":"Carbone","year":"2014","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/bs.apha.2017.05.002_bb0110","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1038\/srep18218","article-title":"Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety","volume":"5","author":"Carnevali","year":"2015","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0115","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3999(02)00311-2","article-title":"Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms","volume":"53","author":"Carney","year":"2002","journal-title":"Journal of Psychosomatic Research"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/can.2016.0002","article-title":"Endocannabinoids and immunity","volume":"1","author":"Chiurchiu","year":"2016","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/imm.12441","article-title":"Endocannabinoid signaling in innate and adaptive immunity","volume":"144","author":"Chiurchiu","year":"2015","journal-title":"Immunology"},{"issue":"16","key":"10.1016\/bs.apha.2017.05.002_bb0130","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6604","key":"10.1016\/bs.apha.2017.05.002_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006409","article-title":"CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis","volume":"4","author":"Cs\u00f3ka","year":"2009","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.2009.00608.x","article-title":"Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and \u2018cannabinoid-like\u2019 receptors in small arteries","volume":"159","author":"Daly","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0150","doi-asserted-by":"crossref","first-page":"R1765","DOI":"10.1152\/ajpregu.00398.2011","article-title":"Cannabinoid and GABA modulation of sympathetic nerve activity and blood pressure in the dorsal periaqueductal gray of the rat","volume":"301","author":"Dean","year":"2011","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0155","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1096\/fj.09-129478","article-title":"The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia\/reperfusion-induced cardiomyopathy","volume":"23","author":"Defer","year":"2009","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2017.05.002_bb0160","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despr\u00e9s","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/ATVBAHA.108.176362","article-title":"Effect of rimonabant on the high-triglyceride\/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: The ADAGIO-lipids trial","volume":"29","author":"Despr\u00e9s","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/bs.apha.2017.05.002_bb9000","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI119677","article-title":"Production and physiological actions of anandamide in the vasculature of the rat kidney","volume":"100","author":"Deutsch","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"issue":"5090","key":"10.1016\/bs.apha.2017.05.002_bb0170","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.114.094649","article-title":"CB2 cannabinoid receptors as a therapeutic target\u2014What does the future hold?","volume":"86","author":"Dhopeshwarkar","year":"2014","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0180","first-page":"1","article-title":"Endocannabinoids: Synthesis and degradation","volume":"Vol. 160","author":"Di Marzo","year":"2006"},{"issue":"16","key":"10.1016\/bs.apha.2017.05.002_bb0185","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"Suppl. 2","key":"10.1016\/bs.apha.2017.05.002_bb0190","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.STR.0000251441.89665.bc","article-title":"Stroke-induced immunodepression: Experimental evidence and clinical relevance","volume":"38","author":"Dirnagl","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/bs.apha.2017.05.002_bb9005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/ATVBAHA.108.168757","article-title":"Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice","volume":"29","author":"Dol-Gleizes","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0195","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/bcp.12920","article-title":"Implications of the BIA-102474-101 study for review of first-into-human clinical trials","volume":"81","author":"Eddleston","year":"2016","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0200","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0091-3057(97)00386-9","article-title":"Acute and residual effects of marijuana in humans","volume":"60","author":"Fant","year":"1998","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/bs.apha.2017.05.002_bb0205","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: From preclinical models to clinical applications","volume":"12","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpcardio0938","article-title":"Mechanisms of disease: Toll-like receptors in cardiovascular disease","volume":"4","author":"Frantz","year":"2007","journal-title":"Nature Clinical Practice Cardiovascular Medicine"},{"key":"10.1016\/bs.apha.2017.05.002_bb0215","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis if an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"Journal of the American Chemical Society"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2017.05.002_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2009.03.021","article-title":"Enhancement of the hypotensive effects of intrathecally injected endocannabinoids by the entourage compound palmitoylethanolamide","volume":"610","author":"Garc\u00eda Mdel","year":"2009","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0225","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/sj.bjp.0704649","article-title":"Complex regional haemodynamic effects of anandamide in conscious rats","volume":"135","author":"Gardiner","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0230","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1476-5381.2009.00363.x","article-title":"Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats","volume":"158","author":"Gardiner","year":"2009","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0235","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.01.021","article-title":"Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids","volume":"62","author":"Gaskari","year":"2015","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0240","doi-asserted-by":"crossref","first-page":"H1344","DOI":"10.1152\/ajpheart.00537.2004","article-title":"Endothelium-derived 2-arachidonylglycerol: An intermediate in vasodilatory eicosanoid release in bovine coronary arteries","volume":"288","author":"Gauthier","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0245","first-page":"H2085","article-title":"Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current","volume":"266","author":"Gebremedhin","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2017.05.002_bb9010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2790129","article-title":"Molecular cloning of a human cannabinoid receptor which is also expressed in testis","volume":"279","author":"Gerard","year":"1991","journal-title":"Biochemical Journal"},{"key":"10.1016\/bs.apha.2017.05.002_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2929-0_1","article-title":"Use of mouse models in atherosclerosis research","volume":"1339","author":"Getz","year":"2015","journal-title":"Methods in Molecular Biology"},{"issue":"11","key":"10.1016\/bs.apha.2017.05.002_bb0255","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.chembiol.2010.08.013","article-title":"Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects","volume":"17","author":"Godlewski","year":"2010","journal-title":"Chemistry & Biology"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0260","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1124\/jpet.108.144717","article-title":"The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channels","volume":"328","author":"Godlewski","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0265","doi-asserted-by":"crossref","first-page":"754.e1","DOI":"10.1016\/j.ahj.2005.11.006","article-title":"The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers","volume":"151","author":"Gorelick","year":"2006","journal-title":"American Heart Journal"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0270","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/bph.13226","article-title":"Role of the endocannabinoid system in diabetes and diabetic complications","volume":"173","author":"Gruden","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0275","doi-asserted-by":"crossref","first-page":"741303","DOI":"10.1155\/2013\/741303","article-title":"Cannabinoid receptor 2 protects against acute experimental sepsis in mice","volume":"2013","author":"Gui","year":"2013","journal-title":"Mediators of Inflammation"},{"key":"10.1016\/bs.apha.2017.05.002_bb0280","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrn1902","article-title":"The sympathetic control of blood pressure","volume":"7","author":"Guyenet","year":"2006","journal-title":"Nature Reviews Neuroscience"},{"issue":"25","key":"10.1016\/bs.apha.2017.05.002_bb0285","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","article-title":"HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor","volume":"96","author":"Hanus","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5863\/1551-6776-17.2.177","article-title":"Acute intoxication caused by a synthetic cannabinoid in two adolescents","volume":"17","author":"Heath","year":"2012","journal-title":"Journal of Pediatric Pharmacology and Therapeutics"},{"key":"10.1016\/bs.apha.2017.05.002_bb0295","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterisation and localisation of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"The Journal of Neuroscience"},{"issue":"9","key":"10.1016\/bs.apha.2017.05.002_bb0300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","article-title":"The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants","volume":"30","author":"Hill","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3565(24)39035-4","article-title":"Endocannabinoids and vascular function","volume":"294","author":"Hillard","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.apha.2017.05.002_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2015.10.001","article-title":"The endocannabinoid signaling system in the CNS: A primer","volume":"125","author":"Hillard","year":"2015","journal-title":"International Review of Neurobiology"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0315","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.bjp.0707468","article-title":"Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619","volume":"152","author":"Hillard","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0320","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u2018Entourage\u2019 effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0325","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjp.0705160","article-title":"Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery","volume":"138","author":"Ho","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0330","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-511X-11-32","article-title":"Serum contents of endocannabinoids are correlated with blood pressure in depressed women","volume":"11","author":"Ho","year":"2012","journal-title":"Lipids in Health and Disease"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0335","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1476-5381.2010.00772.x","article-title":"Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex","volume":"160","author":"Ho","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0340","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bjp.0707141","article-title":"Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol","volume":"150","author":"Ho","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"22","key":"10.1016\/bs.apha.2017.05.002_bb0345","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1111\/bph.13312","article-title":"Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol","volume":"172","author":"Ho","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"17","key":"10.1016\/bs.apha.2017.05.002_bb0350","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/0024-3205(84)90278-9","article-title":"Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds","volume":"35","author":"Howlett","year":"1984","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0355","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacological Reviews"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0360","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.yjmcc.2011.08.008","article-title":"Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo","volume":"51","author":"Hoyer","year":"2011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"9","key":"10.1016\/bs.apha.2017.05.002_bb0365","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0370","first-page":"133","article-title":"Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model","volume":"106","author":"Hydock","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0375","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","article-title":"Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves","volume":"118","author":"Ishac","year":"1996","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0380","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.HYP.35.2.679","article-title":"Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice","volume":"35","author":"J\u00e1rai","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2017.05.002_bb0385","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2017.05.002_bb0390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.lfs.2016.07.013","article-title":"Selective activation of CB2 receptor improves efferocytosis in cultured macrophages","volume":"161","author":"Jiang","year":"2016","journal-title":"Life Sciences"},{"issue":"Suppl. 11","key":"10.1016\/bs.apha.2017.05.002_bb0395","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1002\/j.1552-4604.2002.tb06004.x","article-title":"Cardiovascular system effects of marijuana","volume":"42","author":"Jones","year":"2002","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0400","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrd2775","article-title":"End of the line for cannabinoid receptor 1 as an anti-obesity target?","volume":"7","author":"Jones","year":"2008","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0405","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.bjp.0704199","article-title":"Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide","volume":"133","author":"Jonsson","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0410","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000638","article-title":"Cannabis use: Signal of increasing risk of serious cardiovascular disorders","volume":"3","author":"Jouanjus","year":"2014","journal-title":"Journal of the American Heart Association"},{"issue":"11","key":"10.1016\/bs.apha.2017.05.002_bb0415","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1097\/01.CCM.0000187010.14426.CC","article-title":"Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats","volume":"33","author":"Kadoi","year":"2005","journal-title":"Critical Care Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0420","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/187153010791936874","article-title":"The cannabinoid 2 receptor as a potential therapeutic target for sepsis","volume":"10","author":"Kasten","year":"2010","journal-title":"Endocrine, Metabolic & Immune Disorders Drug Targets"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0425","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0430","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/CH-131668","article-title":"Cannabinoid receptor 1 inhibition improves the intestinal microcirculation in experimental endotoxemia","volume":"58","author":"Kianian","year":"2014","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0435","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/01.ASN.0000130561.82631.BC","article-title":"Anandamide decreases glomerular filtration rate through predominant vasodilation of efferent arterioles in rat kidneys","volume":"15","author":"Koura","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/bs.apha.2017.05.002_bb9015","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1097\/HJH.0b013e3282ef7a0a","article-title":"Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery","volume":"25","author":"Koz\u0142owska","year":"2007","journal-title":"Journal of Hypertension"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0440","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00418-015-1321-7","article-title":"A role for GPR55 in human placental venous endothelial cells","volume":"144","author":"Kremshofer","year":"2015","journal-title":"Histochemistry and Cell Biology"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0445","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0706195","article-title":"Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats","volume":"145","author":"Kwolek","year":"2005","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0450","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: From mechanisms to translation","volume":"17","author":"Ladecola","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apha.2017.05.002_bb0455","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.HYP.29.5.1204","article-title":"Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats","volume":"29","author":"Lake","year":"1997","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0460","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","article-title":"The future of endocannabinoid-oriented clinical research after CB1 antagonists","volume":"205","author":"Le Foll","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.apha.2017.05.002_bb0465","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","author":"Ledent","year":"1999","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0470","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.mehy.2014.03.015","article-title":"Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome","volume":"82","author":"Lehmann","year":"2014","journal-title":"Medical Hypotheses"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0475","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/ATVBAHA.112.300275","article-title":"Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice","volume":"33","author":"Lenglet","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0480","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1254\/jphs.CRJ06011X","article-title":"Signaling pathways involved in the cardioprotective effects of cannabinoids","volume":"102","author":"L\u00e9picier","year":"2006","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4\u20135","key":"10.1016\/bs.apha.2017.05.002_bb0485","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000350088","article-title":"Activation of cannabinoid type 2 receptor by JWH133 protects heart against ischemia\/reperfusion-induced apoptosis","volume":"31","author":"Li","year":"2013","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0490","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.bjp.0707517","article-title":"Cannabinoid receptors in acute and chronic complications of atherosclerosis","volume":"153","author":"Maccarrone","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0495","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone","year":"2015","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568010023344878","article-title":"Endocannabinoid degradation, endotoxic shock and inflammation","volume":"1","author":"Maccarrone","year":"2002","journal-title":"Current Drug Targets. Inflammation and Allergy"},{"key":"10.1016\/bs.apha.2017.05.002_bb0505","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2014.03.055","article-title":"Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature","volume":"735","author":"MacIntyre","year":"2014","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0510","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00210-001-0498-6","article-title":"Anandamide and methanandamide induce both vanilloid VR1- and cannabinoids CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats","volume":"364","author":"Malinowska","year":"2001","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0515","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s002100100450","article-title":"Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors","volume":"364","author":"Malinowska","year":"2001","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0520","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00210-010-0497-6","article-title":"Involvement of central beta2-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats","volume":"381","author":"Malinowska","year":"2010","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0525","doi-asserted-by":"crossref","first-page":"498","DOI":"10.5414\/CP202687","article-title":"FAAH inhibitors in the limelight, but regrettably","volume":"54","author":"Mallet","year":"2016","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/bs.apha.2017.05.002_bb9020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2013.09.039","article-title":"Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats","volume":"721","author":"Marichal-Cancino","year":"2013","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0530","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nn.2601","article-title":"The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors","volume":"13","author":"Marrs","year":"2010","journal-title":"Nature Neuroscience"},{"issue":"11","key":"10.1016\/bs.apha.2017.05.002_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142728","article-title":"Circulating endocannabinoids and the polymorphism 385C>a in fatty acid amide hydrolase (FAAH) gene may identify the obesity phenotype related to cardiometabolic risk: A study conducted in a Brazilian population of complex interethnic admixture","volume":"10","author":"Martins","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0540","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1074248415612593","article-title":"Prospects for creation of cardioprotective drugs based on cannabinoid receptor agonists","volume":"21","author":"Maslov","year":"2016","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0545","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/FJC.0000000000000438","article-title":"The effect of chronic activation of the novel endocannabinoid receptor GPR18 on myocardial function and blood pressure in conscious rats","volume":"69","author":"Matouk","year":"2017","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"6284","key":"10.1016\/bs.apha.2017.05.002_bb0550","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/bs.apha.2017.05.002_bb0555","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-Arachidonoyl glycine potently drives directed BV-2 microglial migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neuroscience"},{"key":"10.1016\/bs.apha.2017.05.002_bb0560","series-title":"Role of gpr55 and gpr18 receptors in the vascular actions of endocannabinoids and related lipids","author":"McNaughton","year":"2016"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2017.05.002_bb0565","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2004.03.045","article-title":"Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats","volume":"491","author":"McQueen","year":"2004","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0570","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochemical Pharmacology"},{"issue":"9","key":"10.1016\/bs.apha.2017.05.002_bb0575","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/BF01959156","article-title":"Enantiomeric cannabinoids: Stereospecificity of psychotropic activity","volume":"44","author":"Mechoulam","year":"1988","journal-title":"Experientia"},{"issue":"11","key":"10.1016\/bs.apha.2017.05.002_bb0580","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.apha.2017.05.002_bb0585","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrn1765","article-title":"Central nervous system injury-induced immune deficiency syndrome","volume":"6","author":"Meisel","year":"2005","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/bs.apha.2017.05.002_bb0590","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nucmedbio.2017.01.001","article-title":"Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalu1ation of the novel radiotracer [(11)C]RS-016 targeting CB2 in atherosclerosis","volume":"47","author":"Meletta","year":"2017","journal-title":"Nuclear Medicine and Biology"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0595","doi-asserted-by":"crossref","first-page":"H24","DOI":"10.1152\/ajpheart.00034.2016","article-title":"Microcirculatory dysfunction in sepsis: Pathophysiology, clinical monitoring, and potential therapies","volume":"311","author":"Miranda","year":"2016","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0600","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1194\/jlr.M035147","article-title":"Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formation","volume":"54","author":"Molica","year":"2013","journal-title":"Journal of Lipid Research"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0605","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","article-title":"At the heart of the matter: The endocannabinoid system in cardiovascular function and dysfunction","volume":"33","author":"Montecucco","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"issue":"5","key":"10.1016\/bs.apha.2017.05.002_bb0610","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.yjmcc.2008.12.014","article-title":"CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia\/reperfusion","volume":"46","author":"Montecucco","year":"2009","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0615","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2008.12.040","article-title":"Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis","volume":"205","author":"Montecucco","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.apha.2017.05.002_bb0620","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.bjp.0706313","article-title":"Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation","volume":"146","author":"Movahed","year":"2005","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0625","doi-asserted-by":"crossref","first-page":"H2046","DOI":"10.1152\/ajpheart.00497.2001","article-title":"Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent","volume":"282","author":"Mukhopadhyay","year":"2002","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0630","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2010.11.002","article-title":"Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury","volume":"50","author":"Mukhopadhyay","year":"2011","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0635","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2010.07.060","article-title":"Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic LDLR-null mice","volume":"213","author":"Netherland","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0640","doi-asserted-by":"crossref","first-page":"53","DOI":"10.12970\/2311-052X.2015.03.02.2","article-title":"Cannabinoid receptor type 2 (cb2) dependent and independent effects of WIN55, 212-2 on atherosclerosis in LDLR-null mice","volume":"3","author":"Netherland-Van Dyke","year":"2015","journal-title":"Journal of Cardiology and Therapeutics"},{"key":"10.1016\/bs.apha.2017.05.002_bb0645","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3565(24)39125-6","article-title":"Cannabinoids cause central sympathoexcitation and bradycardia in rabbits","volume":"294","author":"Niederhoffer","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"13","key":"10.1016\/bs.apha.2017.05.002_bb0650","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: The STRADIVARIUS randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/bs.apha.2017.05.002_bb0655","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1124\/mol.63.3.699","article-title":"Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor","volume":"63","author":"Offert\u00e1ler","year":"2003","journal-title":"Molecular Pharmacology"},{"issue":"14","key":"10.1016\/bs.apha.2017.05.002_bb0660","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/hrt.2011.223446","article-title":"Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: The AUDITOR trial","volume":"97","author":"O'Leary","year":"2011","journal-title":"Heart"},{"key":"10.1016\/bs.apha.2017.05.002_bb0665","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-3-319-20825-1_14","article-title":"Endocannabinoids and the cardiovascular system in health and disease","volume":"231","author":"O'Sullivan","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"12","key":"10.1016\/bs.apha.2017.05.002_bb0670","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0675","doi-asserted-by":"crossref","first-page":"425289","DOI":"10.1155\/2009\/425289","article-title":"Time-dependent vascular effects of endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPAR\u03b3)","volume":"2009","author":"O'Sullivan","year":"2009","journal-title":"PPAR Research"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0680","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbrc.2005.09.121","article-title":"Novel time-dependent vascular actions of \u03949-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma","volume":"337","author":"O'Sullivan","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"Suppl. 1","key":"10.1016\/bs.apha.2017.05.002_bb0685","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1038\/sj.bjp.0707529","article-title":"GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity","volume":"153","author":"Overton","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"Pt. 2","key":"10.1016\/bs.apha.2017.05.002_bb0690","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1113\/jphysiol.2004.064824","article-title":"Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice","volume":"558","author":"Pacher","year":"2004","journal-title":"The Journal of Physiology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0695","doi-asserted-by":"crossref","first-page":"H533","DOI":"10.1152\/ajpheart.00107.2005","article-title":"Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase","volume":"289","author":"Pacher","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0700","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0707582","article-title":"Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning","volume":"153","author":"Pacher","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0705","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system?","volume":"50","author":"Pacher","year":"2011","journal-title":"Progress in Lipid Research"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0710","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00281-009-0145-8","article-title":"The emerging role of the endocannabinoid system in cardiovascular disease","volume":"31","author":"Pacher","year":"2009","journal-title":"Seminars in Immunopathology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0715","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.bjp.0705422","article-title":"Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats","volume":"140","author":"Padley","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb9030","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1476-5381.2009.00622.x","article-title":"N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels","volume":"160","author":"Parmar","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0720","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40268-016-0127-y","article-title":"Safety, tolerability and pharmacokinetics of FAAH inhibitor V158866: A double-blind, randomised, placebo-controlled phase I study in healthy volunteers","volume":"16","author":"Pawsey","year":"2016","journal-title":"Drugs in R&D"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0725","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/jpet.114.216036","article-title":"Neuronal nitric oxide synthase-dependent elevation in adiponectin in the rostral ventrolateral medulla underlies g protein-coupled receptor 18-mediated hypotension in conscious rats","volume":"351","author":"Penumarti","year":"2014","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"Suppl. 1","key":"10.1016\/bs.apha.2017.05.002_bb0730","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: The first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-20825-1_1","article-title":"Endocannabinoids and their pharmacological actions","volume":"231","author":"Pertwee","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb9040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apha.2017.05.002_bb0740","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tips.2016.12.002","article-title":"Modern history of medical cannabis: From widespread use to prohibitionism and back","volume":"38","author":"Pisanti","year":"2017","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1 Pt. 2","key":"10.1016\/bs.apha.2017.05.002_bb0745","first-page":"H375","article-title":"N-Arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor","volume":"274","author":"Pratt","year":"1998","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.12.023","article-title":"Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function","volume":"231","author":"Quercioli","year":"2017","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0755","doi-asserted-by":"crossref","first-page":"H2694","DOI":"10.1152\/ajpheart.00978.2004","article-title":"U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: Evidence for functional relevance","volume":"288","author":"Rademacher","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0760","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/db11-0477","article-title":"Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy","volume":"61","author":"Rajesh","year":"2012","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0765","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","article-title":"CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion","volume":"293","author":"Rajesh","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0770","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bjp.0707569","article-title":"CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration","volume":"153","author":"Rajesh","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0775","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jacc.2010.03.034","article-title":"Anxiety and risk of incident coronary heart disease: A meta-analysis","volume":"56","author":"Roest","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0780","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-013-9445-9","article-title":"Cannabinoid receptor 2: Potential role in immunomodulation and neuroinflammation","volume":"8","author":"Rom","year":"2013","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0785","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706687","article-title":"Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: Evidences for CB1 receptors, nitric oxide and potassium channels","volume":"147","author":"Romano","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"1\u20133","key":"10.1016\/bs.apha.2017.05.002_bb0790","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejphar.2012.02.049","article-title":"Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery","volume":"683","author":"Romano","year":"2012","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0795","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","article-title":"The enigmatic pharmacology of GPR55","volume":"30","author":"Ross","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0800","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/HJH.0b013e3282f2d625","article-title":"Effect of rimonabant on blood pressure in overweight\/obese patients with\/without co-morbidities: Analysis of pooled RIO study results","volume":"26","author":"Ruilope","year":"2008","journal-title":"Journal of Hypertension"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0805","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"Pt B","key":"10.1016\/bs.apha.2017.05.002_bb0810","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yebeh.2016.09.040","article-title":"Cannabis and epilepsy: An ancient treatment returns to the fore","volume":"70","author":"Russo","year":"2017","journal-title":"Epilepsy & Behavior"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0815","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0820","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/bjp.2008.335","article-title":"Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain","volume":"155","author":"Sagar","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0825","doi-asserted-by":"crossref","first-page":"978678","DOI":"10.1155\/2014\/978678","article-title":"Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis","volume":"2014","author":"Sardinha","year":"2014","journal-title":"Mediators of Inflammation"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0830","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ajh.2008.198","article-title":"A human fatty acid amide hydrolase (FAAH) functional gene variant is associated with lower blood pressure in young males","volume":"21","author":"Sarzani","year":"2008","journal-title":"American Journal of Hypertension"},{"issue":"9","key":"10.1016\/bs.apha.2017.05.002_bb0835","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nature Neuroscience"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2017.05.002_bb0840","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0009-3084(02)00157-3","article-title":"Cell signaling by endocannabinoids and their congeners: Questions of selectivity and other challenges","volume":"121","author":"Schmid","year":"2002","journal-title":"Chemistry and Physics of Lipids"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0845","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00210-005-0007-4","article-title":"Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta","volume":"372","author":"Schultheiss","year":"2005","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0850","doi-asserted-by":"crossref","first-page":"H992","DOI":"10.1152\/ajpheart.00870.2003","article-title":"Anandamide conent, and interaction of endocannabinoid\/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition","volume":"286","author":"Seagard","year":"2004","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0855","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/bs.apha.2017.05.002_bb9200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","article-title":"Pharmacological characterization of GPR55, a putative cannabinoid receptor","volume":"126","author":"Sharir","year":"2010","journal-title":"Pharmacology and Therapeutics"},{"issue":"8","key":"10.1016\/bs.apha.2017.05.002_bb0860","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0865","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00109-013-1034-0","article-title":"Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome","volume":"91","author":"Slavic","year":"2013","journal-title":"Journal of Molecular Medicine"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb0870","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.bjp.0704732","article-title":"\u2018Entourage\u2019 effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism","volume":"136","author":"Smart","year":"2002","journal-title":"British Journal of Pharmacology"},{"issue":"Pt. A","key":"10.1016\/bs.apha.2017.05.002_bb0875","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.phrs.2016.08.028","article-title":"The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries","volume":"113","author":"Stanley","year":"2016","journal-title":"Pharmacological Research"},{"key":"10.1016\/bs.apha.2017.05.002_bb0880","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2014.02.001","article-title":"Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries","volume":"81","author":"Stanley","year":"2014","journal-title":"Pharmacological Research"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060040","article-title":"Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism","volume":"8","author":"Starowicz","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0890","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2012.02042.x","article-title":"Targeting cannabinoid receptor CB(2) in cardiovascular disorders: Promises and controversies","volume":"167","author":"Steffens","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0895","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/1389450115666141202113225","article-title":"The activated endocannabinoid system in atherosclerosis: Driving force or protective mechanism?","volume":"16","author":"Steffens","year":"2015","journal-title":"Current Drug Targets"},{"issue":"7034","key":"10.1016\/bs.apha.2017.05.002_bb0900","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0905","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.811992","article-title":"Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages","volume":"119","author":"Sugamura","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0910","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.apha.2017.05.002_bb0915","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mce.2015.01.012","article-title":"Endocannabinoid-mediated modulation of Gq\/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension","volume":"403","author":"Szekeres","year":"2015","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.apha.2017.05.002_bb0920","author":"Temporary Specialist Scientific Committee (TSSC)"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0925","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pharep.2015.10.004","article-title":"Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats","volume":"68","author":"Toczek","year":"2016","journal-title":"Pharmacological Reports"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb0930","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/bph.12545","article-title":"Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis","volume":"171","author":"Toguri","year":"2014","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb0935","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CH-151996","article-title":"Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation","volume":"61","author":"Toguri","year":"2015","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"9740","key":"10.1016\/bs.apha.2017.05.002_bb0940","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(10)60935-X","article-title":"Rimonabant for prevention of cardiovascular events (CRESCENDO): A randomised, multicentre, placebo-controlled trial","volume":"376","author":"Topol","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/bs.apha.2017.05.002_bb0945","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2174\/1566524016666151123110310","article-title":"Beyond lipoprotein receptors: Learning from receptor knockouts mouse models about new targets for reduction of the atherosclerotic plaque","volume":"15","author":"Trusca","year":"2015","journal-title":"Current Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0950","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0900203","article-title":"The cannabinoid receptor 2 is critical for the host response to sepsis","volume":"183","author":"Tsch\u00f6p","year":"2009","journal-title":"Journal of Immunology"},{"issue":"4","key":"10.1016\/bs.apha.2017.05.002_bb0955","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbalip.2014.12.015","article-title":"Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases","volume":"1851","author":"Urquhart","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/bs.apha.2017.05.002_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20100539","article-title":"Role of toll-like receptors in cardiovascular diseases","volume":"121","author":"Vallejo","year":"2011","journal-title":"Clinical Science (London, England)"},{"issue":"14","key":"10.1016\/bs.apha.2017.05.002_bb0965","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/eurheartj\/ehn076","article-title":"Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: Two year results from the RIO-Europe study","volume":"29","author":"Van Gaal","year":"2008","journal-title":"European Heart Journal"},{"issue":"5746","key":"10.1016\/bs.apha.2017.05.002_bb0970","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/bs.apha.2017.05.002_bb0975","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/01.HYP.28.4.682","article-title":"Mechanism of the hypotensive action of anandamide in anesthetized rats","volume":"28","author":"Varga","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/bs.apha.2017.05.002_bb0980","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(95)00181-J","article-title":"Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide","volume":"278","author":"Varga","year":"1995","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"10.1016\/bs.apha.2017.05.002_bb0985","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1096\/fasebj.12.11.1035","article-title":"Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension","volume":"12","author":"Varga","year":"1998","journal-title":"The FASEB Journal"},{"key":"10.1016\/bs.apha.2017.05.002_bb0990","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2015.10.109","article-title":"Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice","volume":"244","author":"Vujic","year":"2016","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb0995","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0735-1097(01)01671-0","article-title":"Endogenous cannabinoids mediate hypotension after experimental myocardial infarction","volume":"38","author":"Wagner","year":"2001","journal-title":"American College of Cardiology"},{"key":"10.1016\/bs.apha.2017.05.002_bb1000","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01112-8","article-title":"Hemodynamic effects of cannabinoids: Coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors","volume":"423","author":"Wagner","year":"2001","journal-title":"European Journal of Pharmacology"},{"issue":"6659","key":"10.1016\/bs.apha.2017.05.002_bb1005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/37371","article-title":"Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock","volume":"390","author":"Wagner","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb1010","doi-asserted-by":"crossref","first-page":"H2491","DOI":"10.1152\/ajpheart.00718.2005","article-title":"The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs","volume":"289","author":"Wahn","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"Pt. 10","key":"10.1016\/bs.apha.2017.05.002_bb1015","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1242\/jcs.020958","article-title":"Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression","volume":"121","author":"Waldeck-Weiermair","year":"2008","journal-title":"Journal of Cell Science"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb1020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000065512","article-title":"Complications following acute ischemic stroke","volume":"48","author":"Weimar","year":"2002","journal-title":"European Neurology"},{"issue":"46","key":"10.1016\/bs.apha.2017.05.002_bb1025","doi-asserted-by":"crossref","first-page":"18710","DOI":"10.1073\/pnas.1308130110","article-title":"Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction","volume":"110","author":"Wenzel","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apha.2017.05.002_bb9205","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.bjp.0704333","article-title":"Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries","volume":"134","author":"White","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.apha.2017.05.002_bb1030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20120242","article-title":"Cannabinoids suppress inflammatory and neuropathic pain by targeting \u03b13 glycine receptors","volume":"209","author":"Xiong","year":"2012","journal-title":"The Journal of Experimental Medicine"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132487","article-title":"Time-dependent protection of CB2 receptor agonist in stroke","volume":"10","author":"Yu","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb1040","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1476-5381.2009.00579.x","article-title":"A cannabinoid receptor, sensitive to O-1918, is involved in the delayed hypotension induced by anandamide in anaesthetized rats","volume":"160","author":"Zakrzeska","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"7","key":"10.1016\/bs.apha.2017.05.002_bb1045","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1476-5381.2010.00841.x","article-title":"Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator","volume":"160","author":"Zhang","year":"2010","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.apha.2017.05.002_bb1050","first-page":"246","article-title":"In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe","volume":"5","author":"Zhang","year":"2015","journal-title":"American Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/bs.apha.2017.05.002_bb9210","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejphar.2010.09.027","article-title":"WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice","volume":"649","author":"Zhao","year":"2010","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2017.05.002_bb1055","first-page":"171","article-title":"A new face of endocannabinoids in pharmacotherapy. Part I: Protective role of endocannabinoids in hypertension and myocardial infarction","volume":"65","author":"Zubrzycki","year":"2014","journal-title":"Journal of Physiology and Pharmacology"},{"issue":"12","key":"10.1016\/bs.apha.2017.05.002_bb1060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081618","article-title":"Monoacylglycerols activate TRPV1\u2014A link between phospholipase C and TRPV1","volume":"8","author":"Zygmunt","year":"2013","journal-title":"PloS One"},{"issue":"6743","key":"10.1016\/bs.apha.2017.05.002_bb1065","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Advances in Pharmacology","Cannabinoid Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358917300431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358917300431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:49:52Z","timestamp":1750463392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358917300431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9780128112328"],"references-count":223,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2017.05.002","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}